NYLEXA Trademark

Trademark Overview

On Monday, September 25, 2023, a trademark application was filed for NYLEXA with the United States Patent and Trademark Office. The USPTO has given the NYLEXA trademark a serial number of 79382037. The federal status of this trademark filing is REGISTERED as of Tuesday, September 10, 2024. This trademark is owned by Novabiotics Limited. The NYLEXA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances, namely, anti-microbial preparations and substances for the prevention and treatment of infection
nylexa

General Information

Serial Number79382037
Word MarkNYLEXA
Filing DateMonday, September 25, 2023
Status700 - REGISTERED
Status DateTuesday, September 10, 2024
Registration Number7498002
Registration DateTuesday, September 10, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 25, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances, namely, anti-microbial preparations and substances for the prevention and treatment of infection

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 3, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovabiotics Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB
Party NameNovabiotics Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB
Party NameNovabiotics Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Tuesday, November 7, 2023APPLICATION FILING RECEIPT MAILED
Thursday, October 26, 2023SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Thursday, November 2, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, November 3, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 13, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, December 13, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, December 13, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 13, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 13, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, December 13, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 16, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 16, 2024ASSIGNED TO EXAMINER
Wednesday, June 12, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, June 5, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 13, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, June 14, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, June 25, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 25, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, July 1, 2024NOTIFICATION PROCESSED BY IB
Saturday, July 20, 2024NOTIFICATION PROCESSED BY IB
Tuesday, September 10, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, October 10, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 10, 2024REGISTERED-PRINCIPAL REGISTER

Related Keywords

nylexa preparations substances treatment infection prevention anti namely pharmaceutical microbial